Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons

Journal of Neurochemistry

Volumn 100, Issue 5, 2007, Pages 1300-1314

  Mao, Xianrong ^a   Yang, Shao Hua ^b   Simpkins, James W ^b   Barger, Steven W ^a,c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Astrocyte; Calcium; Excitotoxicity; Ischemia; Sp1

Indexed keywords

CALCIUM; CALPAIN; CYSTEINE PROTEINASE; GLUTAMATE RECEPTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; BRAIN NERVE CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; DNA BINDING; GLIA CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CALPAIN; CELLS, CULTURED; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; ISCHEMIC ATTACK, TRANSIENT; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; REPERFUSION INJURY; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; SP4 TRANSCRIPTION FACTOR;

EID: 33846941574     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04297.x     Document Type: Article

References (59)

1. Bai G. and Kusiak J. W. (1997) Nerve growth factor up-regulates the N-methyl-D-aspartate receptor subunit 1 promoter in PC12 cells. J. Biol. Chem. 272, 5936-5942.
2. Barger S. W. and Basile A. S. (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 76, 846-854.
3. Barger S. W., Moerman A. M. and Mao X. (2005) Molecular mechanisms of cytokine-induced neuroprotection: NFκB and neuroplasticity. Curr. Pharm.Des 11, 985-998.
4. Birnbaum M. J., van Wijnen A. J., Odgren P. R., Last T. J., Suske G., Stein G. S. and Stein J. L. (1995) Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34, 16 503-16 508.
5. Bobba A., Canu N., Atlante A., Petragallo V., Calissano P. and Marra E. (2002) Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons. FEBS Lett. 515, 8-12.
6. Bodles A. M. and Barger S. W. (2005) Secreted β-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol. Aging 26, 9-16.
7. Bouwman P. and Philipsen S. (2002) Regulation of the activity of Sp1-related transcription factors. Mol. Cell Endocrinol. 195, 27-38.
8. Bouwman P., Gollner H., Elsasser H. P., Eckhoff G., Karis A., Grosveld F., Philipsen S. and Suske G. (2000) Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19, 655-661.
9. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14, 187-197.
10. Buddle M., Eberhardt E., Ciminello L. H., Levin T., Wing R., DiPasquale K. and Raley-Susman K. M. (2003) Microtubule-associated protein 2 (MAP2) associates with the NMDA receptor and is spatially redistributed within rat hippocampal neurons after oxygen-glucose deprivation. Brain Res. 978, 38-50.
11. Chen C. S., Chen W. N., Zhou M., Arttamangkul S. and Haugland R. P. (2000) Probing the cathepsin D using a BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy. J. Biochem. Biophys. Methods 42, 137-151.
12. Dawson V. L. and Dawson T. M. (2004) Deadly conversations: nuclear-mitochondrial cross-talk. J. Bioenerg. Biomembr. 36, 287-294.
13. Dunah A. W., Jeong H., Griffin A., Kim Y. M., Standaert D. G., Hersch S. M., Mouradian M. M., Young A. B., Tanese N. and Krainc D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243.
14. Ebralidze A., Wang Y., Petkova V., Ebralidse K. and Junghans R. P. (2004) RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303, 383-387.
15. Goll D. E., Thompson V. F., Li H., Wei W. and Cong J. (2003) The calpain system. Physiol. Rev. 83, 731-801.
16. Gollner H., Bouwman P., Mangold M. et al. (2001) Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. Genes Cells 6, 689-697.
17. Gray J., Haran M. M., Schneider K., Vesce S., Ray A. M., Owen D., White I. R., Cutler P. and Davis J. B. (2001) Evidence that inhibition of cathepsin-B contributes to the neuroprotective properties of caspase inhibitor Tyr-Val-Ala-Asp-chloromethyl ketone. J. Biol. Chem. 276, 32 750-32 755.
18. Hagen G., Dennig J., Preiss A., Beato M. and Suske G. (1995) Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J. Biol. Chem. 270, 24 989-24 994.
19. Hardy M., Younkin D., Tang C. M., Pleasure J., Shi Q. Y., Williams M. and Pleasure D. (1994) Expression of non-NMDA glutamate receptor channel genes by clonal human neurons. J. Neurochem. 63, 482-489.
20. Hartley Z. and Dubinsky J. M. (1993) Changes in intracellular pH associated with glutamate excitotoxicity. J. Neurosci. 13, 4690-4699.
21. Higuchi M., Tomioka M., Takano J., Shirotani K., Iwata N., Masumoto H., Maki M., Itohara S. and Saido T. C. (2005) Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280, 15 229-15 237.
22. Knoblach S. M., Alroy D. A., Nikolaeva M., Cernak I., Stoica B. A. and Faden A. I. (2004) Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J. Cereb. Blood Flow Metab. 24, 1119-1132.
23. Kwon H. S., Kim M. S., Edenberg H. J. and Hur M. W. (1999) Sp3 and Sp4 can repress transcription by competing with Sp1 for the core cis-elements on the human ADH5/FDH minimal promoter. J. Biol. Chem. 274, 20-28.
24. Lankiewicz S., Marc Luetjens C., Truc Bui N., Krohn A. J., Poppe M., Cole G. M., Saido T. C. and Prehn J. H. (2000) Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J. Biol. Chem. 275, 17 064-17 071.
25. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M. and Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
26. Li J., Grynspan F., Berman S., Nixon R. and Bursztajn S. (1996) Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30, 177-191.
27. Liu A., Hoffman P. W., Lu W. and Bai G. (2004) NF-kappaB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J. Biol. Chem. 279, 17 449-17 458.
28. Mao X., Moerman A. M., Lucas M. M. and Barger S. W. (1999) Inhibition of the activity of a neuronal κB-binding factor (NKBF) by glutamate. J. Neurochem. 73, 1851-1858.
29. Mao X., Moerman A. M. and Barger S. W. (2002) Neuronal κB-binding factors consist of Sp1-related proteins: Functional implications for autoregulation of NR1 expression. J. Biol. Chem. 277, 44 911-44 919.
30. Mao X., Moerman-Herzog A. M., Wang W., Barger S. W. (2006) Differential transcriptional control of the superoxide dismutase κB element in neurons and astrocytes. J. Biol. Chem. 281, 35 863-35 872.
31. Marin M., Karis A., Visser P., Grosveld F. and Philipsen S. (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 89, 619-628.
32. Moerman A. M. and Barger S. W. (1999) Inhibition of AMPA responses by mutated presenilin 1. J. Neurosci. Res. 57, 962-967.
33. Moerman A. M., Mao X., Lucas M. M. and Barger S. W. (1999) Characterization of a neuronal κB-binding factor distinct from NF-κB. Mol. Brain Res. 67, 303-315.
34. Nicolas M., Noe V. and Ciudad C. J. (2003) Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F. Biochem J. 371, 265-275.
35. Okamoto S., Sherman K., Bai G. and Lipton S. A. (2002) Effect of the ubiquitous transcription factors, SP1 and MAZ, on NMDA receptor subunit type 1 (NR1) expression during neuronal differentiation. Brain Res. Mol. Brain Res. 107, 89-96.
36. Piedrafita F. J. and Pfahl M. (1997) Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation. Mol. Cell Biol. 17, 6348-6358.
37. Pleasure S. J. and Lee V. M. (1993) NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35, 585-602.
38. Polster B. M., Basanez G., Etxebarria A., Hardwick J. M. and Nicholls D. G. (2005) Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J. Biol. Chem. 280, 6447-6454.
39. Ray S. K. and Banik N. L. (2003) Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr. Drug Targets CNS Neurol. Disord. 2, 173-189.
40. Ray S. K., Matzelle D. C., Wilford G. G., Hogan E. L. and Banik N. L. (2000) E-64-d prevents both calpain upregulation and apoptosis in the lesion and penumbra following spinal cord injury in rats. Brain Res. 867, 80-89.
41. Rickers A., Peters N., Badock V., Beyaert R., Vandenabeele P., Dorken B. and Bommert K. (1999) Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis. Eur. J. Biochem. 261, 269-274.
42. Ryu H., Lee J., Zaman K., Kubilis J., Ferrante R. J., Ross B. D., Neve R. and Ratan R. R. (2003) Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J. Neurosci. 23, 3597-3606.
43. Saito K., Elce J. S., Hamos J. E. and Nixon R. A. (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl Acad. Sci. USA 90, 2628-2632.
44. Sakai T., Furukawa T., Iwanari H., Oka C., Nakano T., Kawaichi M. and Honjo T. (1995) Loss of immunostaining of the RBP-J kappa transcription factor upon F9 cell differentiation induced by retinoic acid. J. Biochem. (Tokyo) 118, 621-628.
45. Sapetschnig A., Koch F., Rischitor G., Mennenga T. and Suske G. (2004) Complexity of translationally controlled transcription factor Sp3 isoform expression. J. Biol. Chem. 279, 42 095-42 105.
46. Siman R., Noszek J. C. and Kegerise C. (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9, 1579-1590.
47. Simon R. P., Swan J. H., Griffiths T. and Meldrum B. S. (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852.
48. Song J., Mangold M., Suske G., Geltinger C., Kanazawa I., Sun K. and Yokoyama K. K. (2001) Characterization and promoter analysis of the mouse gene for transcription factor Sp4. Gene 264, 19-27.
49. Su K., Roos M. D., Yang X., Han I., Paterson A. J. and Kudlow J. E. (1999) An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J. Biol. Chem. 274, 15 194-15 202.
50. Supp D. M., Witte D. P., Branford W. W., Smith E. P. and Potter S. S. (1996) Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility. Dev. Biol. 176, 284-299.
51. Suske G. (1999) The Sp-family of transcription factors. Gene 238, 291-300.
52. Takano J., Tomioka M., Tsubuki S., Higuchi M., Iwata N., Itohara S., Maki M. and Saido T. C. (2005) Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280, 16 175-16 184.
53. Wang K. K., Posmantur R., Nadimpalli R., Nath R., Mohan P., Nixon R. A., Talanian R. V., Keegan M., Herzog L. and Allen H. (1998) Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356, 187-196.
54. Wang H., Yu S. W., Koh D. W., Lew J., Coombs C., Bowers W., Federoff H. J., Poirier G. G., Dawson T. M. and Dawson V. L. (2004) Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci. 24, 10963-10973.
55. Wei F. Y., Tomizawa K., Ohshima T. et al. (2005) Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 93, 502-512.
56. Wu S.-Z., Bodles A. M., Porter M. M., Griffin W. S. T., Basile A. S. and Barger S. W. (2004) Induction of serine racemase expression and D-serine release from microglia by amyloid b-peptide. J. Neuroinflammation 1, 2-12.
57. Yang S. H., Perez E., Cutright J., Liu R., He Z., Day A. L. and Simpkins J. W. (2002) Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J. Appl. Physiol. 92, 195-201.
58. Zhang J., Miyamoto K., Hashioka S., Hao H. P., Murao K., Saido T. C. and Nakanishi H. (2003) Activation of μ-calpain in developing cortical neurons following methylmercury treatment. Dev. Brain Res. 142, 105-110.
59. Zhou X., Long J. M., Geyer M. A., Masliah E., Kelsoe J. R., Wynshaw-Boris A. and Chien K. R. (2005) Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Mol. Psychiatry 10, 393-406.